CIK 0001505512
RGLS Regulus Therapeutics Inc.
Insider trading from SEC Form 4. Last filing Jun 27, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
12
with a Form 4 at this company
Signals
Open-market buys and sells at Regulus Therapeutics Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 36Weak | Preston Klassen President & Head of R & D buy | $96k 12,000 shares | +33% | - | |
| 33Weak | David Baltimore director buy | $21k 19,610 shares | +766% | - | |
| 46Moderate | Joseph P Hagan Chief Executive Officer buy | $54k 50,000 shares | +24% | - | |
| 27Weak | Christopher Ray Aker Sr. VP & General Counsel sell | $55k 43,635 shares | -47% | - | |
| 34Weak | Crispina Calsada Chief Financial Officer sell | $55k 43,804 shares | -49% | - | |
| 41Moderate | Joseph P Hagan Chief Executive Officer sell | $160k 127,054 shares | -38% | - | |
| 31Weak | Preston Klassen President & Head of R & D sell | $40k 31,445 shares | -47% | - |
Transactions
The last 100 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 25, 2025 | Joseph P Hagan Chief Executive Officer | DDisposition to issuer Common Stock | -571,558 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Stelios Papadopoulos director | UTender of shares Common Stock | -976,253 | - | - | 64,635 | Jun 27, 2025 |
| Jun 25, 2025 | Alice Shih-hou Huang director | UTender of shares Common Stock | -5,208 | - | - | 57,292 | Jun 27, 2025 |
| Jun 25, 2025 | Kathryn J Collier director | DDisposition to issuer Common Stock | -75,565 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Hugh Rosen director | UTender of shares Common Stock | -6,979 | - | - | 57,292 | Jun 27, 2025 |
| Jun 25, 2025 | David Baltimore director | UTender of shares Common Stock | -27,377 | - | - | 57,292 | Jun 27, 2025 |
| Jun 25, 2025 | Jason Raleigh Nunn director | DDisposition to issuer Common Stock | -62,500 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | William H Rastetter director | UTender of shares Common Stockindirect: By The Rastetter Family Trust | -44,264 | - | - | 57,292 | Jun 27, 2025 |
| Jun 25, 2025 | Pascale Witz director | DDisposition to issuer Common Stock | -67,233 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Preston Klassen President & Head of R & D | DDisposition to issuer Common Stock | -115,555 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Crispina Calsada Chief Financial Officer | DDisposition to issuer Common Stock | -140,228 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Christopher Ray Aker Sr. VP & General Counsel | UTender of shares Common Stock | -60,796 | - | - | 83,125 | Jun 27, 2025 |
| Jun 25, 2025 | Hugh Rosen director | DDisposition to issuer Common Stock | -57,292 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Alice Shih-hou Huang director | DDisposition to issuer Common Stock | -57,292 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Pascale Witz director | DDisposition to issuer Stock Optionderivative | -4,650 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Jason Raleigh Nunn director | DDisposition to issuer Stock Optionderivative | -4,650 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Kathryn J Collier director | DDisposition to issuer Stock Optionderivative | -4,650 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Crispina Calsada Chief Financial Officer | DDisposition to issuer Stock Optionderivative | -10,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | David Baltimore director | DDisposition to issuer Common Stock | -57,292 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Christopher Ray Aker Sr. VP & General Counsel | DDisposition to issuer Common Stock | -83,125 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Preston Klassen President & Head of R & D | DDisposition to issuer Stock Optionderivative | -350,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Stelios Papadopoulos director | DDisposition to issuer Common Stock | -64,635 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Joseph P Hagan Chief Executive Officer | DDisposition to issuer Stock Optionderivative | -6,500 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | William H Rastetter director | DDisposition to issuer Common Stockindirect: By The Rastetter Family Trust | -57,292 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Alice Shih-hou Huang director | UTender of shares Common Stockindirect: By Spouse | -27,377 | - | - | 57,292 | Jun 27, 2025 |
| Jun 25, 2025 | Crispina Calsada Chief Financial Officer | DDisposition to issuer Stock Optionderivative | -21,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Joseph P Hagan Chief Executive Officer | DDisposition to issuer Stock Optionderivative | -1,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | David Baltimore director | UTender of shares Common Stockindirect: By Spouse | -5,208 | - | - | 57,292 | Jun 27, 2025 |
| Jun 25, 2025 | Hugh Rosen director | DDisposition to issuer Stock Optionderivative | -4,650 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Preston Klassen President & Head of R & D | DDisposition to issuer Stock Optionderivative | -225,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Jason Raleigh Nunn director | DDisposition to issuer Stock Optionderivative | -2,325 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Pascale Witz director | DDisposition to issuer Stock Optionderivative | -2,325 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Stelios Papadopoulos director | DDisposition to issuer Stock Optionderivative | -4,650 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | William H Rastetter director | DDisposition to issuer Stock Optionderivativeindirect: By The Rastetter Family Trust | -4,650 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Kathryn J Collier director | DDisposition to issuer Stock Optionderivative | -9,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Christopher Ray Aker Sr. VP & General Counsel | DDisposition to issuer Stock Optionderivative | -2,500 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Alice Shih-hou Huang director | DDisposition to issuer Common Stockindirect: By Spouse | -57,292 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | David Baltimore director | DDisposition to issuer Common Stockindirect: By Spouse | -57,292 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Crispina Calsada Chief Financial Officer | DDisposition to issuer Stock Optionderivative | -15,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Christopher Ray Aker Sr. VP & General Counsel | DDisposition to issuer Stock Optionderivative | -750 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Hugh Rosen director | DDisposition to issuer Stock Optionderivative | -2,325 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Stelios Papadopoulos director | DDisposition to issuer Stock Optionderivative | -2,325 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Jason Raleigh Nunn director | DDisposition to issuer Stock Optionderivative | -4,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Kathryn J Collier director | DDisposition to issuer Stock Optionderivative | -30,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Joseph P Hagan Chief Executive Officer | DDisposition to issuer Stock Optionderivative | -100,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Preston Klassen President & Head of R & D | DDisposition to issuer Stock Optionderivative | -120,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Pascale Witz director | DDisposition to issuer Stock Optionderivative | -4,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | William H Rastetter director | DDisposition to issuer Stock Optionderivativeindirect: By The Rastetter Family Trust | -2,325 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Alice Shih-hou Huang director | DDisposition to issuer Stock Optionderivative | -4,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Crispina Calsada Chief Financial Officer | DDisposition to issuer Stock Optionderivative | -48,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | David Baltimore director | DDisposition to issuer Stock Optionderivative | -4,650 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Christopher Ray Aker Sr. VP & General Counsel | DDisposition to issuer Stock Optionderivative | -33,500 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Preston Klassen President & Head of R & D | DDisposition to issuer Stock Optionderivative | -528,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Jason Raleigh Nunn director | DDisposition to issuer Stock Optionderivative | -9,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Kathryn J Collier director | DDisposition to issuer Stock Optionderivative | -15,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | William H Rastetter director | DDisposition to issuer Stock Optionderivativeindirect: By The Rastetter Family Trust | -4,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Joseph P Hagan Chief Executive Officer | DDisposition to issuer Stock Optionderivative | -90,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Hugh Rosen director | DDisposition to issuer Stock Optionderivative | -4,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Stelios Papadopoulos director | DDisposition to issuer Stock Optionderivative | -4,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Pascale Witz director | DDisposition to issuer Stock Optionderivative | -9,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Alice Shih-hou Huang director | DDisposition to issuer Stock Optionderivative | -9,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Crispina Calsada Chief Financial Officer | DDisposition to issuer Stock Optionderivative | -5,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | David Baltimore director | DDisposition to issuer Stock Optionderivative | -2,325 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Stelios Papadopoulos director | DDisposition to issuer Stock Optionderivative | -9,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Preston Klassen President & Head of R & D | DDisposition to issuer Stock Optionderivative | -675,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Jason Raleigh Nunn director | DDisposition to issuer Stock Optionderivative | -30,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Kathryn J Collier director | DDisposition to issuer Stock Optionderivative | -30,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | William H Rastetter director | DDisposition to issuer Stock Optionderivativeindirect: By The Rastetter Family Trust | -9,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Pascale Witz director | DDisposition to issuer Stock Optionderivative | -30,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Christopher Ray Aker Sr. VP & General Counsel | DDisposition to issuer Stock Optionderivative | -21,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Joseph P Hagan Chief Executive Officer | DDisposition to issuer Stock Optionderivative | -160,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Hugh Rosen director | DDisposition to issuer Stock Optionderivative | -9,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Alice Shih-hou Huang director | DDisposition to issuer Stock Optionderivative | -30,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Crispina Calsada Chief Financial Officer | DDisposition to issuer Stock Optionderivative | -45,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | David Baltimore director | DDisposition to issuer Stock Optionderivative | -4,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Hugh Rosen director | DDisposition to issuer Stock Optionderivative | -30,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Jason Raleigh Nunn director | DDisposition to issuer Stock Optionderivative | -15,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Kathryn J Collier director | DDisposition to issuer Stock Optionderivative | -60,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Pascale Witz director | DDisposition to issuer Stock Optionderivative | -15,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Joseph P Hagan Chief Executive Officer | DDisposition to issuer Stock Optionderivative | -30,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | William H Rastetter director | DDisposition to issuer Stock Optionderivativeindirect: By The Rastetter Family Trust | -30,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Stelios Papadopoulos director | DDisposition to issuer Stock Optionderivative | -30,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Christopher Ray Aker Sr. VP & General Counsel | DDisposition to issuer Stock Optionderivative | -48,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Christopher Ray Aker Sr. VP & General Counsel | DDisposition to issuer Stock Optionderivative | -7,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Alice Shih-hou Huang director | DDisposition to issuer Stock Optionderivative | -15,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Stelios Papadopoulos director | DDisposition to issuer Stock Optionderivative | -15,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Crispina Calsada Chief Financial Officer | DDisposition to issuer Stock Optionderivative | -375,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | William H Rastetter director | DDisposition to issuer Stock Optionderivativeindirect: By The Rastetter Family Trust | -15,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | David Baltimore director | DDisposition to issuer Stock Optionderivative | -9,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Jason Raleigh Nunn director | DDisposition to issuer Stock Optionderivative | -30,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Pascale Witz director | DDisposition to issuer Stock Optionderivative | -30,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Hugh Rosen director | DDisposition to issuer Stock Optionderivative | -15,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Joseph P Hagan Chief Executive Officer | DDisposition to issuer Stock Optionderivative | -100,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Alice Shih-hou Huang director | DDisposition to issuer Stock Optionderivative | -30,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Christopher Ray Aker Sr. VP & General Counsel | DDisposition to issuer Stock Optionderivative | -45,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Crispina Calsada Chief Financial Officer | DDisposition to issuer Stock Optionderivative | -85,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | David Baltimore director | DDisposition to issuer Stock Optionderivative | -30,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Jason Raleigh Nunn director | DDisposition to issuer Stock Optionderivative | -60,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | Hugh Rosen director | DDisposition to issuer Stock Optionderivative | -30,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | William H Rastetter director | DDisposition to issuer Stock Optionderivativeindirect: By The Rastetter Family Trust | -30,000 | - | - | 0 | Jun 27, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Christopher Ray AkerSr. VP & General Counsel
- David Baltimoredirector
- Crispina CalsadaChief Financial Officer
- Kathryn J Collierdirector
- Joseph P HaganChief Executive Officer
- Alice Shih-hou Huangdirector
- Preston KlassenPresident & Head of R & D
- Jason Raleigh Nunndirector
- Stelios Papadopoulosdirector
- William H Rastetterdirector
- Hugh Rosendirector
- Pascale Witzdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.